BRACAnalysis
This article was originally published in The Gray Sheet
Executive Summary
Myriad Genetic's breast and ovarian cancer genetic predisposition test is used in CLIA laboratories. It is not a CLIA-waived test, as was reported (1"The Gray Sheet" Sept. 16, 2002, p. 20)...